Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Maria Xilouri, Oeystein Roed Brekk, Alexia Polissidis, Margarita Chrysanthou-Piterou, Ismini Kloukina & Leonidas Stefanis. (2016) Impairment of chaperone-mediated autophagy induces dopaminergic neurodegeneration in rats. Autophagy 12:11, pages 2230-2247.
Read now
Read now
Nada B Lawand, Nayef E Saadé, Omar M El-Agnaf & Bared Safieh-Garabedian. (2015) Targeting α-synuclein as a therapeutic strategy for Parkinson’s disease. Expert Opinion on Therapeutic Targets 19:10, pages 1351-1360.
Read now
Read now
Ling-Yan Su, Hao Li, Li Lv, Yue-Mei Feng, Guo-Dong Li, Rongcan Luo, He-Jiang Zhou, Xiao-Guang Lei, Liang Ma, Jia-Li Li, Lin Xu, Xin-Tian Hu & Yong-Gang Yao. (2015) Melatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA/α-synuclein aggregation. Autophagy 11:10, pages 1745-1759.
Read now
Read now
Articles from other publishers (51)
Matteo Guidetti, Alessandro Bertini, Francesco Pirone, Gessica Sala, Paola Signorelli, Carlo Ferrarese, Alberto Priori & Tommaso Bocci. (2022) Neuroprotection and Non-Invasive Brain Stimulation: Facts or Fiction?. International Journal of Molecular Sciences 23:22, pages 13775.
Crossref
Crossref
Christopher Simon, Tomoko Soga, Nafees Ahemad, Saatheeyavaane Bhuvanendran & Ishwar Parhar. (2022) Kisspeptin-10 Rescues Cholinergic Differentiated SHSY-5Y Cells from α-Synuclein-Induced Toxicity In Vitro. International Journal of Molecular Sciences 23:9, pages 5193.
Crossref
Crossref
Nouara Yahi, Coralie Di Scala, Henri Chahinian & Jacques Fantini. (2021) Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson’s disease. Glycoconjugate Journal 39:1, pages 1-11.
Crossref
Crossref
Rowan Radford, Mathew Wong & Dean L. Pountney. 2022. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1869
1892
.
Tobias Thom, Matthias Schmitz, Anna‐Lisa Fischer, Angela Correia, Susana Correia, Franc Llorens, Anna‐Villar Pique, Wiebke Möbius, Renato Domingues, Saima Zafar, Erik Stoops, Christopher J. Silva, Andre Fischer, Tiago F. Outeiro & Inga Zerr. (2021) Cellular Prion Protein Mediates α‐Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo. Movement Disorders 37:1, pages 39-51.
Crossref
Crossref
Hong Ju Kim & Hyun Chul Koh. (2021) Chaperon-mediated autophagy can regulate diquat-induced apoptosis by inhibiting α-synuclein accumulation cooperatively with macroautophagy. Food and Chemical Toxicology 158, pages 112706.
Crossref
Crossref
Daphne S. Cukierman, Diana F. Lázaro, Pamela SaccoPatrícia R. Ferreira, Renata Diniz, Claudio O. Fernández, Tiago F. Outeiro & Nicolás A. Rey. (2020)
X1INH, an improved next-generation affinity-optimized hydrazonic ligand, attenuates abnormal copper(
i
)/copper(
ii
)-α-Syn interactions and affects protein aggregation in a cellular model of synucleinopathy
. Dalton Transactions 49:45, pages 16252-16267.
Crossref
Crossref
Maria Fouka, Panagiota Mavroeidi, Grigoria Tsaka & Maria Xilouri. (2020) In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Jing Qu, Xiaoxi Ren, Fenqin Xue, Yi He, Ruihua Zhang, Yan Zheng, Haixia Huang, Wei Wang & Jianliang Zhang. (2020) Specific Knockdown of α-Synuclein by Peptide-Directed Proteasome Degradation Rescued Its Associated Neurotoxicity. Cell Chemical Biology 27:6, pages 751-762.e4.
Crossref
Crossref
Carolyn J. Reuland & Frank C. Church. (2020) Synergy between plasminogen activator inhibitor-1, α-synuclein, and neuroinflammation in Parkinson’s disease. Medical Hypotheses 138, pages 109602.
Crossref
Crossref
Yuling Zhao, Matthew J. Haney, Yeon S. Jin, Olga Uvarov, Natasha Vinod, Yueh Z. Lee, Benjamin Langworthy, Jason P. Fine, Myosotys Rodriguez, Nazira El-Hage, Alexander V. Kabanov & Elena V. Batrakova. (2019) GDNF-expressing macrophages restore motor functions at a severe late-stage, and produce long-term neuroprotective effects at an early-stage of Parkinson’s disease in transgenic Parkin Q311X(A) mice. Journal of Controlled Release 315, pages 139-149.
Crossref
Crossref
Juan A. GerezNatalia C. PrymaczokEdward Rockenstein, Uli S. HerrmannPetra SchwarzAnthony AdameRadoslav I. EnchevThibault CourtheouxPaul J. Boersema, Roland RiekMatthias Peter, Adriano Aguzzi, Eliezer MasliahPaola Picotti. (2019) A cullin-RING ubiquitin ligase targets exogenous α-synuclein and inhibits Lewy body–like pathology. Science Translational Medicine 11:495.
Crossref
Crossref
Olga I. Antimonova, Dmitry V. Lebedev, Yana A. Zabrodskaya, Natalia A. Grudinina, Andrey L. Timkovsky, Edward Ramsay, Michael M. Shavlovsky & Vladimir V. Egorov. (2019) Changing times: Fluorescence-lifetime analysis of amyloidogenic SF-IAPP fusion protein. Journal of Structural Biology 205:1, pages 78-83.
Crossref
Crossref
Sang-Bin Lee, Hee-Tae Kim, Hyun Ok Yang & Wooyoung Jang. (2018) Anodal transcranial direct current stimulation prevents methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity by modulating autophagy in an in vivo mouse model of Parkinson’s disease. Scientific Reports 8:1.
Crossref
Crossref
Mohamed Salama, Ali Shalash, Alshimaa Magdy, Marianne Makar, Tamer Roushdy, Mahmoud Elbalkimy, Hanan Elrassas, Passent Elkafrawy, Wael Mohamed & Mohamed B. Abou Donia. (2018) Tubulin and Tau: Possible targets for diagnosis of Parkinson’s and Alzheimer’s diseases. PLOS ONE 13:5, pages e0196436.
Crossref
Crossref
Tony Werner, Ranjeet Kumar, Istvan Horvath, Nathalie Scheers & Pernilla Wittung-Stafshede. (2018) Abundant fish protein inhibits α-synuclein amyloid formation. Scientific Reports 8:1.
Crossref
Crossref
Mark R. Cookson. 2018. The Molecular and Cellular Basis of Neurodegenerative Diseases. The Molecular and Cellular Basis of Neurodegenerative Diseases
117
143
.
Salma Jamal, Anchala Kumari, Aditi Singh, Sukriti Goyal & Abhinav Grover. (2017) Conformational Ensembles of α-Synuclein Derived Peptide with Different Osmolytes from Temperature Replica Exchange Sampling. Frontiers in Neuroscience 11.
Crossref
Crossref
Franziska Richter, Sudhakar R. Subramaniam, Iddo Magen, Patrick Lee, Jane Hayes, Aida Attar, Chunni Zhu, Nicholas R. Franich, Nicholas Bove, Krystal De La Rosa, Jacky Kwong, Frank-Gerrit Klärner, Thomas Schrader, Marie-Françoise Chesselet & Gal Bitan. (2017) A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-Synuclein. Neurotherapeutics 14:4, pages 1107-1119.
Crossref
Crossref
Mrigendra Bir Karmacharya, Binika Hada, So Ra Park & Byung Hyune Choi. (2016) Low-Intensity Ultrasound Decreases α-Synuclein Aggregation via Attenuation of Mitochondrial Reactive Oxygen Species in MPP(+)-Treated PC12 Cells. Molecular Neurobiology 54:8, pages 6235-6244.
Crossref
Crossref
Sushil K Singh, Aloke Dutta & Gyan Modi. (2017) α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease. Future Medicinal Chemistry 9:10, pages 1039-1053.
Crossref
Crossref
Ewa Papuć & Konrad Rejdak. (2016) Anti-MAG autoantibodies are increased in Parkinson’s disease but not in atypical parkinsonism. Journal of Neural Transmission 124:2, pages 209-216.
Crossref
Crossref
I.A. Kuznetsov & A.V. Kuznetsov. (2016) What can trigger the onset of Parkinson's disease – A modeling study based on a compartmental model of α-synuclein transport and aggregation in neurons. Mathematical Biosciences 278, pages 22-29.
Crossref
Crossref
Huichao GongSai ZhangJiangdian WangHaipeng GongJianyang Zeng. (2016) Constructing Structure Ensembles of Intrinsically Disordered Proteins from Chemical Shift Data. Journal of Computational Biology 23:5, pages 300-310.
Crossref
Crossref
Dominic J. Hare & Kay L. Double. (2016) Iron and dopamine: a toxic couple. Brain 139:4, pages 1026-1035.
Crossref
Crossref
Ann-Louise Bergström, Pekka Kallunki & Karina Fog. (2016) Development of Passive Immunotherapies for Synucleinopathies. Movement Disorders 31:2, pages 203-213.
Crossref
Crossref
Maria Xilouri, Oeystein Roed Brekk & Leonidas Stefanis. (2016) Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies. Movement Disorders 31:2, pages 178-192.
Crossref
Crossref
Douglas G. Walker, Lih-Fen Lue, Geidy Serrano, Charles H. Adler, John N. Caviness, Lucia I. Sue & Thomas G. Beach. (2016) Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases. Frontiers in Neuroscience 9.
Crossref
Crossref
Maria Xilouri & Leonidas Stefanis. (2015) Chaperone mediated autophagy to the rescue: A new-fangled target for the treatment of neurodegenerative diseases. Molecular and Cellular Neuroscience 66, pages 29-36.
Crossref
Crossref
Rowan Radford, Alex Rcom-H'cheo-Gauthier, Mathew B. Wong, Emma D. Eaton, Marion Quilty, Catherine Blizzard, Anwar Norazit, Adrian Meedeniya, James C. Vickers, Wei Ping Gai, Gilles J. Guillemin, Adrian K. West, Tracey C. Dickson, Roger Chung & Dean L. Pountney. (2015) The degree of astrocyte activation in multiple system atrophy is inversely proportional to the distance to α-synuclein inclusions. Molecular and Cellular Neuroscience 65, pages 68-81.
Crossref
Crossref
Md Shahaduzzaman, Kevin Nash, Charles Hudson, Masroor Sharif, Bethany Grimmig, Xiaoyang Lin, Ge Bai, Hui Liu, Kenneth E. Ugen, Chuanhai Cao & Paula C. Bickford. (2015) Anti-Human α-Synuclein N-Terminal Peptide Antibody Protects against Dopaminergic Cell Death and Ameliorates Behavioral Deficits in an AAV-α-Synuclein Rat Model of Parkinson’s Disease. PLOS ONE 10:2, pages e0116841.
Crossref
Crossref
Nidhi Joshi, Sujit Basak, Sangeeta Kundu, Goutam De, Anindita Mukhopadhyay & Krishnananda Chattopadhyay. (2015)
Attenuation of the Early Events of α-Synuclein Aggregation: A Fluorescence Correlation Spectroscopy and Laser Scanning Microscopy Study in the Presence of Surface-Coated Fe
3
O
4
Nanoparticles
. Langmuir 31:4, pages 1469-1478.
Crossref
Crossref
Kapil Gudala, Raju Kanukula & Dipika Bansal. (2015) Reduced Risk of Parkinson’s Disease in Users of Calcium Channel Blockers: A Meta-Analysis. International Journal of Chronic Diseases 2015, pages 1-7.
Crossref
Crossref
Aneesha Chauhan & Alexander F. Jeans. (2015) Is Parkinson’s Disease Truly a Prion-Like Disorder? An Appraisal of Current Evidence. Neurology Research International 2015, pages 1-8.
Crossref
Crossref
Huichao Gong, Sai Zhang, Jiangdian Wang, Haipeng Gong & Jianyang Zeng. 2015. Research in Computational Molecular Biology. Research in Computational Molecular Biology
108
121
.
Abid Oueslati, Methodios Ximerakis & Kostas Vekrellis. (2014) Protein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like Propagation. Experimental Neurobiology 23:4, pages 324-336.
Crossref
Crossref
Woojin Scott Kim, Katarina Kågedal & Glenda M Halliday. (2014) Alpha-synuclein biology in Lewy body diseases. Alzheimer's Research & Therapy 6:5-8.
Crossref
Crossref
Gyan Modi, Chandrashekhar Voshavar, Sanjib Gogoi, Mrudang Shah, Tamara Antonio, Maarten E. A. Reith & Aloke K. Dutta. (2014) Multifunctional D2/D3 Agonist D-520 with High in Vivo Efficacy: Modulator of Toxicity of Alpha-Synuclein Aggregates. ACS Chemical Neuroscience 5:8, pages 700-717.
Crossref
Crossref
Donna Crabtree, Matthew Dodson, Xiaosen Ouyang, Michaël Boyer-Guittaut, Qiuli Liang, Mary E. Ballestas, Naomi Fineberg & Jianhua Zhang. (2014) Over-expression of an inactive mutant cathepsin D increases endogenous alpha-synuclein and cathepsin B activity in SH-SY5Y cells. Journal of Neurochemistry 128:6, pages 950-961.
Crossref
Crossref
Hardy J. Rideout & Leonidas Stefanis. (2013) The Neurobiology of LRRK2 and its Role in the Pathogenesis of Parkinson’s Disease. Neurochemical Research 39:3, pages 576-592.
Crossref
Crossref
Johanna Neuner, Severin Filser, Stylianos Michalakis, Martin Biel & Jochen Herms. (2014) A30P α-Synuclein interferes with the stable integration of adult-born neurons into the olfactory network. Scientific Reports 4:1.
Crossref
Crossref
He-Jin Lee, Eun-Jin Bae & Seung-Jae Lee. (2014) Extracellular α-synuclein—a novel and crucial factor in Lewy body diseases. Nature Reviews Neurology 10:2, pages 92-98.
Crossref
Crossref
Yonghwang Ha, Aerin Yang, Seyoung Lee, Kibong Kim, Hyunjeong Liew, Yoo-Hun Suh, Hee-Sung Park & David G. Churchill. (2014) Facile “stop codon” method reveals elevated neuronal toxicity by discrete S87p-α-synuclein oligomers. Biochemical and Biophysical Research Communications 443:3, pages 1085-1091.
Crossref
Crossref
Rowan Radford, Mathew Wong & Dean L. Pountney. 2014. Handbook of Neurotoxicity. Handbook of Neurotoxicity
2157
2180
.
Katerina Melachroinou, Maria Xilouri, Evangelia Emmanouilidou, Roser Masgrau, Panagiota Papazafiri, Leonidas Stefanis & Kostas Vekrellis. (2013) Deregulation of calcium homeostasis mediates secreted α–synuclein-induced neurotoxicity. Neurobiology of Aging 34:12, pages 2853-2865.
Crossref
Crossref
Rituraj Niranjan. (2013) Molecular Basis of Etiological Implications in Alzheimer’s Disease: Focus on Neuroinflammation. Molecular Neurobiology 48:3, pages 412-428.
Crossref
Crossref
Grzegorz A. Czapski, Magdalena Gąssowska, Anna Wilkaniec, Magdalena Cieślik & Agata Adamczyk. (2013) Extracellular alpha‐synuclein induces calpain‐dependent overactivation of cyclin‐dependent kinase 5 in vitro. FEBS Letters 587:18, pages 3135-3141.
Crossref
Crossref
David T. Dexter & Peter Jenner. (2013) Parkinson disease: from pathology to molecular disease mechanisms. Free Radical Biology and Medicine 62, pages 132-144.
Crossref
Crossref
Kurt A. Jellinger. 2013. Emerging Drugs and Targets for Parkinson’s Disease. Emerging Drugs and Targets for Parkinson’s Disease
175
216
.
Elvira Valera & Eliezer Masliah. (2013) Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies. Pharmacology & Therapeutics 138:3, pages 311-322.
Crossref
Crossref
Jung Nam Kim, Min Kyeong Kim, Kyu Suk Cho, Chang Soon Choi, Seung Hwa Park, Sung-Il Yang, So Hyun Joo, Jin Hee Park, Geonho Bahn, Chan Young Shin, He-Jin Lee, Seol-Heui Han & Kyoung Ja Kwon. (2013) Valproic Acid Regulates α-Synuclein Expression through JNK Pathway in Rat Primary Astrocytes. Biomolecules and Therapeutics 21:3, pages 222-228.
Crossref
Crossref